Co-Authors
This is a "connection" page, showing publications co-authored by Lauge Østergaard and Jawad Butt.
Connection Strength
1.584
-
The association between cardiovascular disease admission rates and the coronavirus disease 2019 lockdown and reopening of a nation: a Danish nationwide cohort study. Eur Heart J Qual Care Clin Outcomes. 2022 01 05; 8(1):14-22.
Score: 0.247
-
Incidence of acute coronary syndrome during national lock-down: Insights from nationwide data during the Coronavirus disease 2019 (COVID-19) pandemic. Am Heart J. 2021 02; 232:146-153.
Score: 0.228
-
Incidence of infective endocarditis during the coronavirus disease 2019 pandemic: A nationwide study. Int J Cardiol Heart Vasc. 2020 Dec; 31:100675.
Score: 0.228
-
Effect of COVID-19 on First-Time Acute Stroke and Transient Ischemic Attack Admission Rates and Prognosis in Denmark: A Nationwide Cohort Study. Circulation. 2020 09 22; 142(12):1227-1229.
Score: 0.224
-
Return to the workforce following infective endocarditis-A nationwide cohort study. Am Heart J. 2018 Jan; 195:130-138.
Score: 0.183
-
Temporal changes in infective endocarditis guidelines during the last 12 years: High-level evidence needed. Am Heart J. 2017 Nov; 193:70-75.
Score: 0.182
-
Association Between Male Sex and Outcomes of Coronavirus Disease 2019 (COVID-19)-A Danish Nationwide, Register-based Study. Clin Infect Dis. 2021 12 06; 73(11):e4025-e4030.
Score: 0.061
-
Risk of coronavirus disease 2019 (Covid-19) contraction and severe infection in home- or healthcare professionals. J Infect. 2021 08; 83(2):e12-e14.
Score: 0.059
-
Risk of major cardiovascular events according to educational level before and after the initial COVID-19 public lockdown: a nationwide study. J Epidemiol Community Health. 2021 09; 75(9):829-835.
Score: 0.058
-
Association Between Prescribed Ibuprofen and Severe COVID-19 Infection: A Nationwide Register-Based Cohort Study. Clin Transl Sci. 2020 11; 13(6):1103-1107.
Score: 0.057
-
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality. JAMA. 2020 Jul 14; 324(2):168-177.
Score: 0.056